EVEREST MED (01952) receives 679,000 shares increased by major shareholder Fu Weizeng.

date
07:10 10/06/2026
avatar
GMT Eight
Genting New Shining (01952) announced that the Board of Directors has been informed by the non-executive director and honorary chairman of the Board, Mr. Fu Wei, who is also the major shareholder of the Company, that from June 8, 2026 to June 9, 2026, Convest Capital (as the major shareholder of the Company) has purchased 679,000 shares of the Company's common stock in the market, with a total consideration of approximately HK$18.9 million, at an average price of approximately HK$27.90 per share.
EVEREST MED (01952) announced that Mr. Fu Wei, non-executive director and honorary chairman of the board of directors as well as the major shareholder of the company, informed the board that between June 8, 2026 and June 9, 2026, Cambridge Capital (as the major shareholder of the company) purchased 679,000 ordinary shares of the company in the market, with a total cost of approximately HK$18.9 million, at an average price of approximately HK$27.90 per share. According to Mr. Fu and Cambridge Capital, the purchase of shares through on-market acquisitions was made based on their strong confidence in the future prospects and long-term development of the company. Subject to compliance with applicable laws and regulations, Mr. Fu and Cambridge Capital do not rule out the possibility of further increasing their holdings in the company at the appropriate time.